Related Experiment Video

Updated: May 27, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

5-azacytidine reverses drug resistance in bladder cancer cells

Kavitha Ramachandran1, Edna Gordian, Rakesh Singal

  • 1Sylvester Cancer Center, University of Miami, FL, USA.

Anticancer Research
|November 24, 2011
PubMed
Abstract

Insights

Epigenetic therapy with 5-azacytidine may reverse chemotherapy resistance in bladder cancer. This approach restored sensitivity to cisplatin and docetaxel in resistant cells, offering hope for improved treatment outcomes.

Area of Science:

  • Oncology
  • Cancer Epigenetics
  • Pharmacology

Background:

  • Metastatic and muscle-invasive bladder cancer are often treated with cisplatin chemotherapy.
  • A significant number of patients develop resistance to chemotherapy, with no standard treatment available.
  • Investigating epigenetic modifications offers a potential strategy to overcome drug resistance.

Purpose of the Study:

  • To determine if epigenetic agents can reverse chemotherapy drug resistance in bladder cancer.
  • To examine the role of methylation in drug resistance.
  • To evaluate the effect of 5-azacytidine on chemosensitivity.

Main Methods:

  • Assessed methylation of genes involved in apoptosis and cell cycle regulation in bladder cancer cells.
  • Developed cisplatin- and docetaxel-resistant bladder cancer cell lines.
  • Investigated the impact of target of methylation-induced silencing (TMS1) expression and 5-azacytidine pretreatment on chemosensitivity in wild-type and resistant cells.

Main Results:

  • Observed unidirectional cross-resistance from cisplatin-resistant to docetaxel-resistant UMUC3 cells.
  • Recombinant expression of TMS1 enhanced sensitivity to both cisplatin and docetaxel.
  • Pretreatment with 5-azacytidine restored sensitivity to cisplatin and docetaxel in both wild-type and drug-resistant bladder cancer cells.

Conclusions:

  • Epigenetic therapy, specifically using 5-azacytidine, can potentially restore chemosensitivity in bladder cancer.
  • This study suggests a promising therapeutic strategy for overcoming drug resistance in bladder cancer patients.
  • Targeting epigenetic alterations may represent a novel approach to improve chemotherapy efficacy.

More Related Videos

An Orthotopic Bladder Cancer Model for Gene Delivery Studies07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...